AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
6.41
+0.37 (6.04%)
Sep 3, 2026, 1:53 PM EDT - Market open
AdaptHealth Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 854 | 1,320 | 1,253 | 984 | 2,590 | 3,234 | |
Market Cap Growth | -31.97% | 5.31% | 27.33% | -62.00% | -19.93% | 20.61% |
Enterprise Value | 2,876 | 3,150 | 3,337 | 3,232 | 4,807 | 5,294 |
Last Close Price | 6.04 | 9.96 | 9.52 | 7.29 | 19.22 | 24.46 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 15.14 | - | 40.81 | 22.81 |
Forward PE | - | 11.60 | 9.91 | 9.86 | 15.29 | 15.36 |
PS Ratio | 0.25 | 0.41 | 0.38 | 0.31 | 0.87 | 1.31 |
PB Ratio | 0.58 | 0.87 | 0.79 | 0.67 | 1.20 | 1.57 |
P/FCF Ratio | 8.67 | 6.02 | 5.31 | 6.87 | - | 44.69 |
P/OCF Ratio | 1.45 | 2.19 | 2.31 | 2.05 | 6.93 | 11.73 |
PEG Ratio | - | 1.06 | 1.37 | 0.57 | 0.86 | 0.59 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.85 | 0.97 | 1.02 | 1.01 | 1.62 | 2.15 |
EV/EBITDA Ratio | 4.92 | 5.37 | 5.11 | 4.89 | 8.47 | 10.95 |
EV/EBIT Ratio | 18.10 | 15.40 | 11.58 | 11.60 | 22.25 | 23.47 |
EV/FCF Ratio | 29.36 | 14.36 | 14.15 | 22.57 | - | 73.15 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.49 | 1.25 | 1.35 | 1.57 | 1.08 | 1.15 |
Debt / EBITDA Ratio | 3.14 | 2.90 | 2.95 | 3.19 | 3.75 | 4.46 |
Debt / FCF Ratio | 21.14 | 8.67 | 9.04 | 16.02 | - | 32.86 |
Net Debt / Equity Ratio | 1.46 | 1.18 | 1.28 | 1.51 | 1.06 | 1.08 |
Net Debt / EBITDA Ratio | 3.47 | 3.06 | 3.09 | 3.35 | 4.01 | 4.61 |
Net Debt / FCF Ratio | 20.70 | 8.19 | 8.56 | 15.45 | -129.69 | 30.79 |
Asset Turnover | 0.77 | 0.74 | 0.73 | 0.66 | 0.57 | 0.70 |
Inventory Turnover | 21.38 | 17.64 | 19.82 | 20.87 | 18.63 | 21.34 |
Quick Ratio | 0.64 | 0.71 | 0.92 | 0.88 | 0.90 | 1.02 |
Current Ratio | 1.12 | 1.02 | 1.33 | 1.21 | 1.28 | 1.34 |
Return on Equity (ROE) | -15.22% | -4.25% | 6.23% | -37.23% | 3.46% | 13.47% |
Return on Assets (ROA) | 2.28% | 2.90% | 4.00% | 3.58% | 2.58% | 3.99% |
Return on Invested Capital (ROIC) | 4.61% | 5.91% | 5.52% | 6.87% | 3.70% | 7.05% |
Return on Capital Employed (ROCE) | 4.40% | 5.70% | 7.40% | 7.00% | 4.50% | 4.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -26.89% | -5.37% | 7.22% | -68.99% | 2.68% | 4.83% |
FCF Yield | 11.54% | 16.63% | 18.82% | 14.55% | -0.68% | 2.24% |
Buyback Yield / Dilution | -0.40% | 0.28% | -0.83% | 3.29% | -4.48% | -153.46% |